Intensive chemo tested to shrink bladder tumors before surgery
NCT ID NCT07184021
Summary
This study is testing a more intensive schedule of two chemotherapy drugs (gemcitabine and cisplatin) given before bladder removal surgery. The goal is to see if this approach is safe and effective at shrinking tumors in patients with muscle-invasive bladder cancer. Researchers hope this will lead to better long-term outcomes by treating cancer cells that may have spread before surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for URINARY BLADDER CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Assiut university Hospital-Departement of clinical oncology.
Asyut, Egypt
Contact Email: •••••@•••••
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.